EnilloRing Vaginal Ring (Generic for NuvaRing Vaginal Ring)

– Assessment of pregnancy status (prior to therapy)

– Blood pressure (prior to therapy and yearly)

– Weight (optional; BMI at baseline may be helpful to monitor changes during therapy)

– Assess potential health status changes at routine visits

– If vaginal ring was out of the vagina >3 hours, or the ring free interval was extended for >1 week, and 1 menstrual period is missed, the possibility of pregnancy should be considered. If the ring was used as directed and 2 consecutive menstrual periods are missed, assess pregnancy status before a new dosing cycle is started. In addition, assess pregnancy status if ring was in place >4 weeks.

– Monitor patient for vision changes

– Blood pressure

– Signs and symptoms of thromboembolic disorders

– Signs or symptoms of depression

– Glycemic control in patients with diabetes

– Lipid profiles in patients being treated for hyperlipidemias

– Adequate diagnostic measures, including endometrial sampling, if indicated, should be performed to rule out malignancy in all cases of undiagnosed abnormal vaginal bleeding

– In patients with persistent urinary symptoms, assess for inadvertent urinary bladder insertion if ring is not otherwise located.